2nd Rare Disease Collaboration 2015

2nd Rare Disease Collaboration 2015 covers topics such as:

• Strategies for identifying patient-centered clinical endpoints
• Latest case studies in navigating compassionate access requests
• Proven techniques for helping your patients retain coverage for orphan drugs as the payer landscape changes
• Success stories of pharma/patient partnerships to accelerate clinical trials
• Updates on the regulatory guidelines determining the clinical and market-access development potential for orphan drugs

2nd Rare Disease Collaboration 2015 brings together attendees from:

• Biotechnology, pharmaceutical and medical device companies as well as members of the rare disease community with responsibilities in:
  • Rare Disease Commercialization
  • Rare Disease
  • Reimbursement
  • Genetic Diseases
  • Alliance Management
  • Access Programs
  • Patient Liaison/Patient Advocacy Liaison
  • External Affairs
  • Oncology Clinical Development/Oncology Clinical Operations
  • Medical Advocacy
  • Medical Affairs
  • Clinical Trial Director/Clinical Operations
  • In-licensing/Out-licensing
  • Commercial Development
• Regulatory Law Firms
• Clinical Trial CROs
• Reimbursement/Insurance Industry Law Firms